Saltar al contenido
Merck

Rare Streptomyces N-formyl amino-salicylamides inhibit oncogenic K-Ras.

Organic letters (2014-09-23)
Angela A Salim, Kwang-Jin Cho, Lingxiao Tan, Michelle Quezada, Ernest Lacey, John F Hancock, Robert J Capon
RESUMEN

During a search for inhibitors of oncogenic K-Ras, we detected two known and two new examples of the rare neoantimycin structure class from a liquid cultivation of Streptomyces orinoci, and reassigned/assigned structures to all based on detailed spectroscopic analysis and microscale C3 Marfey's and C3 Mosher chemical degradation/derivatization/analysis. SAR investigations inclusive of the biosynthetically related antimycins and respirantin, and synthetic benzoxazolone, documented a unique N-formyl amino-salicylamide pharmacophore as a potent inhibitor of oncogenic K-Ras.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Doxorrubicina hydrochloride, 98.0-102.0% (HPLC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Doxorrubicina hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Doxorrubicina hydrochloride, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad
USP
Doxorrubicina hydrochloride, United States Pharmacopeia (USP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad